Different aspects in functional dyspepsia

Hepato-Gastroenterology

Volumn 52, Issue 66, 2005, Pages 1782-1791

  Panteris, Vasilios ^a,b   Karamanolis, D G ^a  

^a TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

^b NONE   (Greece)

Author keywords

Endoscopy; Functional dyspepsia; Gastric motility; Gastritis; Helicobacter pylori eradication; Histology; Management; Medications; Motor dysfunction; Non ulcer dyspepsia; Placebo; Psychological factors; Recommendations; Treatment; Visceral hypersensitivity

Indexed keywords

AMITRIPTYLINE; AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; CLOMIPRAMINE; CORTICOTROPIN RELEASING FACTOR; DESIPRAMINE; DOXEPIN; FEDOTOZINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METRONIDAZOLE; MIANSERIN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PLACEBO; PROTON PUMP INHIBITOR; TETRACYCLINE;

ABDOMINAL PAIN; CLINICAL TRIAL; CORRELATION ANALYSIS; DYSPEPSIA; ENDOSCOPIC THERAPY; ENDOSCOPY; ERADICATION THERAPY; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; META ANALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; STOMACH EMPTYING; STOMACH MOTILITY; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; CLINICAL TRIALS; CROSS-SECTIONAL STUDIES; DYSPEPSIA; FEMALE; FOLLOW-UP STUDIES; GASTRIC MUCOSA; GASTROINTESTINAL MOTILITY; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INCIDENCE; MALE; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 28544448221     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Talley NJ, Stanghellini V, Heading RC, Koch KL, Malagelada JR, Tytgat GN: Functional gastroduodenal disorders. Gut 1999; 45(Suppl 2):II37-II42.
2. Lazzaroni M, Bargiggia S, Sangaletti O, Maconi G, Boldorini M, Bianchi PG: Eradication of Helicobacter pylori and long-term outcome of functional dyspepsia. A clinical endoscopic study. Dig Dis Sci 1996; 41:1589-1594.
3. Sheu BS, Lin CY, Lin XZ, Shiesh SC, Yang HB, Chen CY: Long-term outcome of triple therapy in Helicobacter pylori-related nonulcer dyspepsia: a prospective controlled assessment. Am J Gastroenterol 1996; 91:441-447.
4. Gilvarry J, Buckley MJ, Beattie S, Hamilton H, O'Morain CA: Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. Scand J Gastroenterol 1997; 32:535-540.
5. McColl K, Murray L, El Omar E, Dickson A, El Nujumi A, Wirz A, Kelman A, Penny C, Knill-Jones R, Hilditch T: Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998; 339:1869-1874.
6. Wulbrand U, Feldman M, Pfestroff A, Fehman HC, Du J, Hiltunen J, Marquez M, Arnold R, Westlin JE, Nilsson S, Holmberg AR: A novel somatostatin conjugate with a high affinity to all five somatostatin receptor subtypes. Cancer 2002; 94:1293-1297.
7. Blum AL, Talley NJ, O'Morain C, van Zanten SV, Labenz J, Stolte M, Louw JA, Stubberod A, Theodors A, Sundin M, Bolling-Sternevald E, Junghard O: Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. N Engl J Med 1998; 339:1875-1881.
8. Talley NJ, Janssens J, Lauritsen K, Racz I, Bolling-Sternevald E: Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group. BMJ 1999; 318:833-837.
9. Veldhuyzen van Zanten SJ, Talley NJ, Blum AL, Bolling-Sternevald E, Sundin M, Junghard O: Combined analysis of the ORCHID and OCAY studies: does eradication of Helicobacter pylori lead to sustained improvement in functional dyspepsia symptoms? Gut 2002; 50(Suppl 4):iv26-30; discussion iv31-2.:iv26-iv30.
10. Bazzoli F, De Luca L, Pozzato P, Zagari RM, Fossi S, Ricciardiello L, Nicolini G, Berretti D, Roda E: Helicobacter pylori and functional dyspepsia: review of previous studies and commentary on new data. Gut 2002; 50(Suppl 4):iv33-iv35.
11. Greenberg PD, Cello JP: Lack of effect of treatment for Helicobacter pylori on symptoms of nonulcer dyspepsia. Arch Intern Med 1999; 159:2283-2288.
12. Catalano F, Branciforte G, Brogna A, Bentivegna C, Luca S, Terranova R, Michalos A, Dawson BK, Chodash HB: Helicobacter pylori-positive functional dyspepsia in elderly patients: comparison of two treatments. Dig Dis Sci 1999; 44:863-867.
13. Blum AL, Arnold R, Stolte M, Fischer M, Koelz HR: Short course acid suppressive treatment for patients with functional dyspepsia: results depend on Helicobacter pylori status. The Frosch Study Group. Gut 2000; 47:473-480.
14. Miwa H, Hirai S, Nagahara A, Murai T, Nishira T, Kikuchi S, Takei Y, Watanabe S, Sato N: Cure of Helicobacter pylori infection does not improve symptoms in nonulcer dyspepsia patients-a double-blind placebo-controlled study. Aliment Pharmacol Ther 2000; 14:317-324.
15. Hsu PI, Lai KH, Tseng HH, Lo GH, Lo CC, Lin CK, Cheng JS, Chan HH, Ku MK, Peng NJ, Chien EJ, Chen W, Hsu PN: Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia. Aliment Pharmacol Ther 2001; 15:195-201.
16. Koskenpato J, Farkkila M, Sipponen P: Helicobacter pylori eradication and standardized 3-month omeprazole therapy in functional dyspepsia. Am J Gastroenterol 2001; 96:2866-2872.
17. Froehlich F, Gonvers JJ, Wietlisbach V, Burnand B, Hildebrand P, Schneider C, Saraga E, Beglinger C, Vader JP: Helicobacter pylori eradication treatment does not benefit patients with nonulcer dyspepsia. Am J Gastroenterol 2001; 96:2329-2336.
18. Koelz HR, Arnold R, Stolte M, Fischer M, Blum AL: Treatment of Helicobacter pylori in functional dyspepsia resistant to conventional management: a double blind randomised trial with a six month follow up. Gut 2003; 52:40-46.
19. Malfertheiner P: Helicobacter pylori eradication in functional dyspepsia: new evidence for symptomatic benefit. Eur J Gastroenterol Hepatol 2001; 13(Suppl 2):S9-11.
20. Veldhuyzen VZ, Fedorak RN, Lambert J, Cohen L, Vanjaka A: Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia. Am J Gastroenterol 2003; 98:1963-1969.
21. Kamada T, Haruma K, Hata J, Kusunoki H, Sasaki A, Ito M, Tanaka S, Yoshihara M: The long-term effect of Helicobacter pylori eradication therapy on symptoms in dyspeptic patients with fundic atrophic gastritis. Aliment Pharmacol Ther 2003; 18:245-252.
22. Werdmuller BF, van der Putten TB, Balk TG, Lamers CB, Loffeld RJ: Clinical presentation of Helicobacter pylori -positive and -negative functional dyspepsia. J Gastroenterol Hepatol 2000; 15:498-502.
23. Heikkinen M, Farkkila M: Long-term outcome of functional dyspepsia: effect of Helicobacter pylori infection. A 6-to 7-year follow-up study. Scand J Gastroenterol 2002; 37:905-910.
24. McNamara D, Buckley M, Gilvarry J, O'Morain C: Does Helicobacter pylori eradication affect symptoms in nonulcer dyspepsia: a 5-year follow-up study. Helicobacter 2002; 7:317-321.
25. Heikkinen M, Mayo K, Megraud F, Vornanen M, Marin S, Pikkarainen P, Julkunen R: Association of CagA-positive and CagA-negative Helicobacter pylori strains with patients' symptoms and gastritis in primary care patients with functional upper abdominal complaints. Scand J Gastroenterol 1998; 33:31-38.
26. Loffeld RJ, Werdmuller BF, Kusters JG, Kuipers EJ: Functional dyspepsia is associated with cagA-positive Helicobacter pylori strains. Scand J Gastroenterol 2001; 36:351-355.
27. Holtmann G, Gschossmann J, Holtmann M, Talley NJ: H. pylori and functional dyspepsia: increased serum antibodies as an independent risk factor? Dig Dis Sci 2001; 46:1550-1557.
28. Sheu BS, Yang HB, Wang YL, Chuang CH, Huang AH, Wu JJ: Pretreatment gastric histology is helpful to predict the symptomatic response after H. pylori eradication in patients with nonulcer dyspepsia. Dig Dis Sci 2001; 46:2700-2707.
29. Spiller RC: Is there any difference in Helicobacter pylori eradication rates in patients with active peptic ulcer, inactive peptic ulcer and functional dyspepsia? Eur J Gastroenterol Hepatol 1999; 11(Suppl 2):S25-S28; discussion S43-S5.
30. Armstrong D: Helicobacter pylori infection and dyspepsia. Scand J Gastroenterol Suppl 1996; 215:38-47.
31. Talley NJ, Quan C: Review article: Helicobacter pylori and nonulcer dyspepsia. Aliment Pharmacol Ther 2002; 16(Suppl 1):58-65.
32. Kawamura A, Adachi K, Takashima T, Murao M, Katsube T, Yuki M, Watanabe M, Kinoshita Y: Prevalence of functional dyspepsia and its relationship with Helicobacter pylori infection in a Japanese population. J Gastroenterol Hepatol 2001; 16:384-388.
33. Malfertheiner P, Megraud F, O'Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G: Current concepts in the management Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002; 16:167-180.
34. Stanghellini V, Barbara G, de Giorgio R, Tosetti C, Cogliandro R, Cogliandro L, Salvioli B, Corinaldesi R: Review article: Helicobacter pylori, mucosal inflammation and symptom perception-new insights into an old hypothesis. Aliment Pharmacol Ther 2001; 15(Suppl 1):28-32.
35. Rhee PL, Kim YH, Son HJ, Kim JJ, Koh KC, Paik SW, Rhee JC, Choi KW: Lack of association of Helicobacter pylori infection with gastric hypersensitivity or delayed gastric emptying in functional dyspepsia. Am J Gastroenterol 1999; 94:3165-3169.
36. Parente F, Imbesi V, Maconi G, Cucino C, Manzionna G, Vago L, Bianchi PG: Effects Helicobacter pylori eradication on gastric function indices in functional dyspepsia. A prospective controlled study. Scand J Gastroenterol 1998; 33:461-467.
37. Koskenpato J, Korppi-Tommola T, Kairemo K, Farkkila M: Long-term follow-up study of gastric emptying and Helicobacter pylori eradication among patients with functional dyspepsia. Dig Dis Sci 2000; 45:1763-1768.
38. Talley NJ, Verlinden M, Jones M: Can symptoms discriminate among those with delayed or normal gastric emptying in dysmotility-like dyspepsia? Am J Gastroenterol 2001; 96:1422-1428.
39. van der Schaar PJ, Straathof JW, Veenendaal RA, Lamers CB, Masclee AA: Does Helicobacter pylori gastritis affect motor function of proximal stomach in dyspeptic patients? Dig Dis Sci 2001; 46:1833-1838.
40. Stanghellini V, Corinaldesi R, Tosetti C: Relevance of gastrointestinal motor disturbances in functional dyspepsia. Baillieres Clin Gastroenterol 1998; 12:533-544.
41. Schmulson MJ, Mayer EA: Gastrointestinal sensory abnormalities in functional dyspepsia. Baillieres Clin Gastroenterol 1998; 12:545-556.
42. Kyzekova J, Mour J: The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and Helicobacter pylori infection. Prospective randomized intervention study. Hepatogastroenterology 1999; 46:2048-2056.
43. Feinle-Bisset C, Vozzo R, Horowitz M, Talley NJ: Diet, food intake, and disturbed physiology in the pathogenesis of symptoms in functional dyspepsia. Am J Gastroenterol 2004; 99:170-181.
44. Camilleri M: Testing the sensitivity hypothesis in practice: tools and methods, assumptions and pitfalls. Gut 2002; 51 (Suppl 1):i34-i40.
45. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J: Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121:526-535.
46. Andrews PL, Sanger GJ: Abdominal vagal afferent neurones: an important target for the treatment of gastrointestinal dysfunction. Curr Opin Pharmacol 2002; 2:650-656.
47. Park DI, Rhee PL, Kim YH, Sung IK, Son HJ, Kim JJ, Paik SW, Rhee JC, Choi KW: Role of autonomic dysfunction in patients with functional dyspepsia. Dig Liver Dis 2001; 33:464-471.
48. Bouin M, Meunier P, Riberdy-Poitras M, Poitras P: Pain hypersensitivity in patients with functional gastrointestinal disorders: a gastrointestinal- specific defect or a general systemic condition? Dig Dis Sci 2001; 46:2542-2548.
49. Monnikes H, Tebbe JJ, Hildebrandt M, Arck P, Osmanoglou E, Rose M, Klapp B, Wiedenmann B, Heymann-Monnikes I: Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity. Dig Dis 2001; 19:201-211.
50. Li Y, Nie Y, Sha W, Su H: The link between psychosocial factors and functional dyspepsia: an epidemiological study. Chin Med J (Engl) 2002; 115:1082-1084.
51. Nyren O: Secretory abnormalities in functional dyspepsia. Scand J Gastroenterol Suppl 1991; 182:25-28.
52. Lee KJ, Vos R, Janssens J, Tack J: Influence of duodenal acidification on the sensorimotor function of the proximal stomach in humans. Am J Physiol Gastrointest Liver Physiol 2004; 286:G278-G284.
53. Johnsen R, Bernersen B, Straume B, Forde OH, Bostad L, Burhol PG: Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. BMJ 1991; 302:749-752.
54. Joshi A, Gupta SD, Ahuja V, Sharma MP: Symptom score does not correlate with gastritis grade and Helicobacter pylori infection in non ulcer dyspepsia. Trop Gastroenterol 2001; 22:194-196.
55. Edenholm M, Gustavsson R, Jansson O, Lingfors H, Nilsson O, Soderlind T, Titusson L, Thulin A: Endoscopic findings in patients with ulcer-like dyspepsia. Scand J Gastroenterol Suppl 1985; 109:163-167.
56. Kyzekove J, Arlt J, Arltova M: Is there any relationship between functional dyspepsia and chronic gastritis associated with Helicobacter pylori infection? Hepatogastroenterology 2001; 48:594-602.
57. Koskenpato J, Farkkila M, Sipponen P: Helicobacter pylori and different topographic types of gastritis: treatment response after successful eradication therapy in functional dyspepsia. Scand J Gastroenterol 2002; 37:778-784.
58. Bernersen B, Johnsen R, Straume B, Burhol PG: Erosive prepyloric changes in dyspeptics and non-dyspeptics in a defined population. The Sorreisa Gastrointestinal Disorder Study. Scand J Gastroenterol 1992; 27:233-237.
59. Tytgat GN: Role of endoscopy and biopsy in the work up of dyspepsia. Gut 2002; 50(Suppl 4):iv13-iv16.
60. Mearin F, Balboa A, Zarate N, Cucala M, Malagelada JR: Placebo in functional dyspepsia: symptomatic, gastrointestinal motor, and gastric sensorial responses. Am J Gastroenterol 1999; 94:116-125.
61. Bytzer P: H(2) receptor antagonists and prokinetics in dyspepsia: a critical review. Gut 2002; 5(Suppl 4):iv58-iv62.
62. Dattilo M, Figura N: Helicobacter pylori infection, chronic gastritis, and proton pump inhibitors. J Clin Gastroenterol 1998; 27(Suppl 1):S163-S169.
63. Talley NJ, Meineche-Schmidt V, Pare P, Duckworth M, Raisanen P, Pap A, Kordecki H, Schmid V: Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998; 12:1055-1065.
64. Bolling-Sternevald E, Lauritsen K, Aalykke C, Havelund T, Knudsen T, Unge P, Ekstrom P, Jaup B, Norrby A, Stubberod A, Melen K, Carlsson R, Jerndal P, Junghard O, Glise H: Effect of profound acid suppression in functional dyspepsia: a double-blind, randomized, placebo-controlled trial. Scand J Gastroenterol 2002; 37:1395-1402.
65. Wong WM, Wong BC, Hung WK, Yee YK, Yip AW, Szeto ML, Fung FM, Tong TS, Lai KC, Hu WH, Yuen MF, Lam SK: Double blind, randomised, placebo controlled study of four weeks of lansoprazole for the treatment of functional dyspepsia in Chinese patients. Gut 2002; 51:502-506.
66. Jackson JL, O'Malley PG, Tomkins G, Balden E, Santoro J, Kroenke K: Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000; 108:65-72.
67. Delvaux M: Pharmacology and clinical experience with fedotozine. Expert Opin Investig Drugs 2001; 10:97-110.
68. Tack J, Sarnelli G: Serotonergic modulation of visceral sensation: upper gastrointestinal tract. Gut 2002; 5(Suppl 1):i77-i80.
69. Malfertheiner P, Mossner J, Fischbach W, Layer P, Leodolter A, Stolte M, Demleitner K, Fuchs W: Helicobacter pylori eradication is beneficial in the treatment of functional dyspepsia. Aliment Pharmacol Ther 2003; 18:615-625.
70. Bolling-Sternevald E, Lauritsen K, Talley NJ, Junghard O, Glise H: Is it possible to predict treatment response to a proton pump inhibitor in functional dyspepsia? Aliment Pharmacol Ther 2003; 18:117-124.
71. Talley NJ, Lam SK, Goh KL, Fock KM: Management guidelines for uninvestigated and functional dyspepsia in the Asia-Pacific region: First Asian Pacific Working Party on Functional Dyspepsia. J Gastroenterol Hepatol 1998; 13:335-353.
72. Talley NJ: Dyspepsia: management guidelines for the millennium. Gut 2002; 5(Suppl 4):iv72-iv8; discussion iv79.
73. Calvert EL, Houghton LA, Cooper P, Morris J, Whorwell PJ: Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology 2002; 123:1778-1785.
74. Wallace MB, Durkalski VL, Vaughan J, Palesch YY, Libby ED, Jowell PS, Nickl NJ, Schutz SM, Leung JW, Cotton PB: Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study. Gut 2001; 49:29-34.
75. Hsu PI, Lai KH, Lo GH, Tseng HH, Lo CC, Chen HC, Tsai WL, Jou HS, Peng NJ, Chien CH, Chen JL, Hsu PN: Risk factors for ulcer development in patients with nonulcer dyspepsia: a prospective two year follow up study of 209 patients. Gut 2002; 51:15-20.